Randomized trial of hyperthermic intraperitoneal chemotherapy (HIPEC) in women with primary advanced peritoneal, ovarian, and tubal cancer

被引：84
|
作者：
Lim, Myong Cheol
Chang, Suk-Joon
Yoo, Heong Jong
Nam, Byung-Ho
Bristow, Robert
Park, Sang-Yoon
机构：
[1] Natl Canc Ctr, Seoul, South Korea
[2] Ajou Univ Hosp, Suwon, South Korea
[3] Chungnam Natl Univ Hosp, Chungnam, South Korea
[4] Natl Canc Ctr, Res Inst & Hosp, Div Canc Epidemiol & Prevent, Biometr Res Branch, Goyang, South Korea
[5] Univ Calif Irvine, Med Ctr, Orange, CA USA
[6] Natl Canc Ctr, Res Inst & Hosp, Ctr Uterine Canc, Goyang, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.5520
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5520
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer
    Bakrin, N.
    Classe, J. M.
    Pomel, C.
    Gouy, S.
    Chene, G.
    Glehen, O.
    JOURNAL OF VISCERAL SURGERY, 2014, 151 (05) : 347 - 353
  • [2] HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) FOR OVARIAN CANCER
    van Driel, W. J.
    Koole, S.
    Sikorska, K.
    van Leeuwen, J. Schagen
    Schreuder, H. W.
    Hermans, R.
    de HIngh, I.
    van der Velden, J.
    Arts, H.
    Massuger, L.
    Aalbers, A.
    Verwaal, V.
    Kieffer, J.
    van der Vijver, K.
    van Tinteren, H.
    Aaronson, N.
    Sonke, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 2037 - 2037
  • [3] Hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer
    van Driel, W. J.
    Koole, S.
    Sikorska, K.
    van Leeuwen, J. Schagen
    Schreuder, H. W.
    Hermans, R.
    de Hingh, I.
    van der Velden, J.
    Arts, H.
    Massuger, L.
    Aalbers, A.
    Verwaal, V.
    Kieffer, J.
    van der Vijver, K.
    van Tinteren, H.
    Aaronson, N.
    Sonke, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 12 - 12
  • [4] HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) IN OVARIAN CANCER
    Salvai, M.
    Riege, R. M.
    Costa, J.
    Santillan, G.
    Rosso, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A136 - A136
  • [5] Debate on hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer
    Van Driel, Willemin
    Vergote, Ignace
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (04) : 454 - 455
  • [6] Citoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian cancer
    Aguiar, S.
    Ferreira, F. O.
    Barroso, A.
    Rossi, B. M.
    Nakagawa, W. T.
    Melo, C. A.
    Lopes, A.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 116 - 116
  • [7] A phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer
    Van Driel, Willemien
    Sikorska, Karolina
    van Leeuwen, Jules Schagen
    Schreuder, Henk
    Hermans, Ralph
    de Hingh, Ignace
    Van Der Velden, Jacobus
    Arts, Henriette J. G.
    Leon, Massuger
    Aalbers, Arend
    Victorj, Verwaal J.
    van der Vijver, Koen
    Aaronson, Neil K.
    Sonke, Gabe S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] There is no role for hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer
    Schwameis, Richard
    Chiva, Luis
    Harter, Philipp
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (04) : 578 - 578
  • [9] Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of ovarian cancer
    Graham, Radha
    MacDonald, Nicola D.
    Mould, Tim A.
    Kotsopoulos, Ioannis C.
    OBSTETRICIAN & GYNAECOLOGIST, 2024, 26 (02): : 76 - 83
  • [10] The Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer
    Helm, C. William
    ONCOLOGIST, 2009, 14 (07): : 683 - 694
12345